NSB 2.70% 3.8¢ neuroscientific biopharmaceuticals ltd

Patent for Copaxone ceased in 2014 , but pesumbaly the two...

  1. 1,488 Posts.
    lightbulb Created with Sketch. 264
    Patent for Copaxone ceased in 2014 , but pesumbaly the two companies are working together as NSB would need to source Copaxone part of the product or the news story attached (dated 2018) might also explain https://www.fiercepharma.com/pharma/facing-generics-from-mylan-and-novartis-teva-loses-patent-appeal-copaxone "Teva's patent failure gives long-acting Copaxone generics free rein"
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $5.495M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $1.52K 40K

Buyers (Bids)

No. Vol. Price($)
3 73649 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 13500 1
View Market Depth
Last trade - 12.22pm 19/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.